Rho Capital Partners’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Rho Capital Partners’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,766,666	Closed	-$57.4M	–	5
2022 Q1	$57.4M	Hold	3,766,666	–	–	39.74%	2
2021 Q4	$66.7M	Hold	3,766,666	–	–	43.3%	2
2021 Q3	$79.2M	Hold	3,766,666	–	–	44.14%	2
2021 Q2	$74.3M	Hold	3,766,666	–	–	6.8%	3
2021 Q1	$109M	Hold	3,766,666	–	–	10.53%	3
2020 Q4	$114M	Hold	3,766,666	–	–	60.06%	1
2020 Q3	$59.9M	Hold	3,766,666	–	–	49.9%	1
2020 Q2	$74.4M	Hold	3,766,666	–	–	48.16%	1
2020 Q1	$46.4M	Hold	3,766,666	–	–	46.79%	1
2019 Q4	$69.6M	Sell	3,766,666 -1	-0%	-$15	52.94%	1
2019 Q3	$52.2M	Hold	3,766,667	–	–	43.68%	2
2019 Q2	$55.1M	Buy	+3,766,667	New	+$55.1M	38.25%	2

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return